Cigna Group
CINYSECIK 1739940FinancialsFiscal year ends Dec 31
Reports and events: 177 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-02-1506:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950159-24-000100 |
| 2024-02-1316:06 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-007429 |
| 2024-02-0708:27 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-005982 |
| 2024-02-0206:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950159-24-000033 |
| 2024-01-3108:12 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950159-24-000025 |
| 2024-01-2218:40 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950159-24-000017 |
| 2024-01-1709:21 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950159-24-000014 |
| 2023-12-2906:15 ET | 8-K | 7.01 Regulation FD disclosure | 0000950159-23-000321 |
| 2023-12-1106:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950159-23-000317 |
| 2023-12-0406:15 ET | 8-K | 7.01 Regulation FD disclosure | 0000950159-23-000315 |
| 2023-11-0211:18 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001739940-23-000025 |
| 2023-11-0206:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950159-23-000272 |
| 2023-09-1516:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950159-23-000267 |
| 2023-09-1106:15 ET | 8-K | 7.01 Regulation FD disclosure | 0000950159-23-000258 |
| 2023-08-0310:36 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001739940-23-000020 |
| 2023-08-0306:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950159-23-000227 |
| 2023-06-0506:15 ET | 8-K | 7.01 Regulation FD disclosure | 0000950159-23-000204 |
| 2023-05-0510:50 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001739940-23-000016 |
| 2023-05-0506:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950159-23-000159 |
| 2023-05-0106:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950159-23-000157 |
| 2023-04-2806:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events | 0000950159-23-000155 |
| 2023-04-2716:39 ET | 8-K | 5.07 Shareholder vote results | 0000950159-23-000152 |
| 2023-03-1716:02 ET | DEF 14A | Proxy statement | 0001140361-23-012300 |
| 2023-03-0716:38 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-23-010511 |
| 2023-02-2706:15 ET | 8-K | 7.01 Regulation FD disclosure | 0000950159-23-000112 |
| 2023-02-2313:11 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001739940-23-000008 |
| 2023-02-1306:15 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000950159-23-000019 |
| 2023-02-0306:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950159-23-000017 |
| 2022-12-3006:15 ET | 8-K | 7.01 Regulation FD disclosure | 0000950159-22-000255 |
| 2022-11-3006:15 ET | 8-K | 7.01 Regulation FD disclosure | 0000950159-22-000250 |
| 2022-11-0310:36 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001739940-22-000025 |
| 2022-11-0306:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950159-22-000227 |
| 2022-10-2816:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000950159-22-000220 |
| 2022-09-1306:15 ET | 8-K | 7.01 Regulation FD disclosure | 0000950159-22-000207 |
| 2022-08-0413:10 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001739940-22-000019 |
| 2022-08-0406:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950159-22-000182 |
| 2022-06-1607:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950159-22-000171 |
| 2022-06-0306:15 ET | 8-K | 7.01 Regulation FD disclosure | 0000950159-22-000169 |
| 2022-05-0916:45 ET | 8-K/A | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950159-22-000110 |
| 2022-05-0610:38 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001739940-22-000012 |
| 2022-05-0606:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950159-22-000107 |
| 2022-05-0216:46 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950159-22-000104 |
| 2022-04-2916:16 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950159-22-000102 |
| 2022-03-1816:30 ET | DEF 14A | Proxy statementPeriod 2022-04-27 | 0001140361-22-010160 |
| 2022-02-2412:08 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001739940-22-000007 |
| 2022-02-2406:15 ET | 8-K | 7.01 Regulation FD disclosure | 0000950159-22-000084 |
| 2022-02-0306:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950159-22-000018 |
| 2022-01-2406:15 ET | 8-K | 7.01 Regulation FD disclosure | 0000950159-22-000010 |
| 2021-12-2706:15 ET | 8-K | 7.01 Regulation FD disclosure | 0000950159-21-000364 |
| 2021-12-0816:30 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000950159-21-000343 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 5, 2026, 13:13 ET. Listed shows no prices and gives no investment advice.